Paydirt
VL
Insider

Versant Vantage II GP-GP, LLC

10% owner

Versant Vantage II GP-GP, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in LENZ. The largest single filing was $10.3M of LENZ (224,674 sh across 4 lots, as filed), executed Sep 30 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.3M
shares × price, as filed
Last traded
Sep 30 2025
Filed Oct 2 2025
Open performance
Volume by month
$10.3M$5.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2025 · sells $10.2MJul 2025 · sells $6.1MOct 2025 · sells $10.3M
Buys $0 Sells $26.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
LENZ LENZ LENZ · 0 buys · 3 sells 3 filings
Recent filings
LENZSALE LENZ Therapeutics, Inc. View filing → $10.3M
224,674 sh across 4 lots
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET
LENZSALE LENZ Therapeutics, Inc. View filing → $6.1M
200,000 sh × $30.47
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET
LENZSALE LENZ Therapeutics, Inc. View filing → $10.2M
350,000 sh × $29.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET